Related Experiment Video
Updated: Jan 20, 2026
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Sodium-Glucose Cotransporter-2 Inhibitors, Reverse J-Curve Pattern, and Mortality in Heart Failure
Konstantinos Imprialos1, Konstantinos Stavropoulos1, Vasilios Papademetriou1
1VAMC and Georgetown University, 50 Irving Street, Washington, DC 20422, USA.
Abstract:
The prevalence of diabetes mellitus and heart failure is increasing. The novel sodium-glucose cotransporters 2 inhibitors offer multidimensional ameliorating effects on cardiovascular and heart failure risk factors. Several studies have assessed the impact on cardiovascular events, with data suggesting beneficial effects on cardiovascular events in high-risk patients with diabetes in patients with heart failure. The reverse J-curve pattern between blood pressure levels and mortality has emerged as an important topic in the field of heart failure. There is no significant evidence to propose any potential effect of sodium-glucose co-transporter 2 inhibitors on the J-shape-suggested mortality in patients with heart failure.
Insights
Sodium-glucose cotransporter 2 inhibitors show promise for managing cardiovascular and heart failure risks in diabetic patients. However, their impact on the J-curve mortality pattern in heart failure remains unproven.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Increasing prevalence of diabetes mellitus and heart failure globally.
- Growing interest in sodium-glucose cotransporter 2 (SGLT2) inhibitors for cardiovascular benefits.
- Emerging evidence on SGLT2 inhibitors in high-risk diabetic patients with heart failure.
Purpose of the Study:
- To evaluate the effects of SGLT2 inhibitors on cardiovascular and heart failure risk factors.
- To assess the impact of SGLT2 inhibitors on cardiovascular events in patients with diabetes and heart failure.
- To investigate the potential influence of SGLT2 inhibitors on the reverse J-curve mortality pattern in heart failure.
Main Methods:
- Review of existing studies and clinical trial data.
- Analysis of cardiovascular event rates in patients treated with SGLT2 inhibitors.
- Examination of mortality data in relation to blood pressure and SGLT2 inhibitor use.
Main Results:
- SGLT2 inhibitors demonstrate beneficial effects on cardiovascular and heart failure risk factors.
- Data suggests positive impacts on cardiovascular events in high-risk diabetic patients with heart failure.
- No significant evidence currently links SGLT2 inhibitors to the J-curve mortality pattern in heart failure.
Conclusions:
- SGLT2 inhibitors offer significant advantages in managing cardiovascular risks associated with diabetes and heart failure.
- Further research is needed to understand the relationship between SGLT2 inhibitors and heart failure mortality, particularly concerning the J-curve phenomenon.
More Related Videos
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
05:25Detection of Phosphorylated Neuronal Potassium-Chloride Cotransporter 2 via Western Blotting
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
01:29Heart Failure II: Pathophysiology